Business
2026.01.30 20:51 GMT+8
AstraZeneca CEO: Investing in Chinese market essential for innovation
Updated 2026.01.30 20:51 GMT+8
CGTN
Due to the booming development of the Chinese market and China's fundamental role in innovation ecosystems, AstraZeneca plans to invest 100 billion yuan ($14.2 billion) in China for research and production, said Pascal Soriot, CEO of AstraZeneca.
Copyright ©
RELATED STORIES
{{#contents.0.videos}}{{/contents.0.videos}}
{{#contents.0.pictures}}
CHOOSE YOUR LANGUAGE
- Albanian Shqip
- Arabic العربية
- Belarusian Беларуская
- Bengali বাংলা
- Bulgarian Български
- Cambodian ខ្មែរ
- Croatian Hrvatski
- Czech Český
- English English
- Esperanto Esperanto
- Filipino Filipino
- French Français
- German Deutsch
- Greek Ελληνικά
- Hausa Hausa
- Hebrew עברית
- Hungarian Magyar
- Hindi हिन्दी
- Indonesian Bahasa Indonesia
- Italian Italiano
- Japanese 日本語
- Korean 한국어
- Lao ລາວ
- Malay Bahasa Melayu
- Mongolian Монгол
- Myanmar မြန်မာဘာသာ
- Nepali नेपाली
- Persian فارسی
- Polish Polski
- Portuguese Português
- Pashto پښتو
- Romanian Română
- Russian Русский
- Serbian Српски
- Sinhalese සිංහල
- Spanish Español
- Swahili Kiswahili
- Tamil தமிழ்
- Thai ไทย
- Turkish Türkçe
- Ukrainian Українська
- Urdu اردو
- Vietnamese Tiếng Việt
Copyright © 2024 CGTN.
京ICP备20000184号
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466